Cargando…

Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir

Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yeon-Gu, Park, Hyeon Jeong, Yim, Sunmin, Lee, Heun Joo, Choi, Young Jun, Kim, Won-Serk, Lee, Ga-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608398/
https://www.ncbi.nlm.nih.gov/pubmed/37853866
http://dx.doi.org/10.5021/ad.21.074
_version_ 1785127770985070592
author Choi, Yeon-Gu
Park, Hyeon Jeong
Yim, Sunmin
Lee, Heun Joo
Choi, Young Jun
Kim, Won-Serk
Lee, Ga-Young
author_facet Choi, Yeon-Gu
Park, Hyeon Jeong
Yim, Sunmin
Lee, Heun Joo
Choi, Young Jun
Kim, Won-Serk
Lee, Ga-Young
author_sort Choi, Yeon-Gu
collection PubMed
description Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class.
format Online
Article
Text
id pubmed-10608398
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-106083982023-10-28 Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir Choi, Yeon-Gu Park, Hyeon Jeong Yim, Sunmin Lee, Heun Joo Choi, Young Jun Kim, Won-Serk Lee, Ga-Young Ann Dermatol Case Report Fixed drug eruption (FDE) is a well-defined hyperpigmented patch that recurs in a fixed location each time a particular drug is taken. Common causative agents of FDE are non-steroidal anti-inflammatory drugs, non-narcotic analgesics, sedatives, anticonvulsants, sulfonamides, and tetracycline. We report a 33-year-old male who presented with a recurrent, localized, brownish-to-erythematous macule and papules on the peri-philtrum area two hours after taking valacyclovir. Three episodes of valacyclovir ingestion for treatment of Herpes simplex virus infection provoked a similar skin rash at the same site. Histopathology results showed vacuolar degeneration in the basal layer of the epidermis, pigmentary incontinence, and perivascular inflammatory cell infiltration in the papillary dermis. Although patch test and skin prick test showed negative responses to acyclovir and valacyclovir, an intradermal test showed a positive reaction only to valacyclovir. The oral provocation test to acyclovir and valacyclovir showed a positive reaction only to valacyclovir. Through drug history, histopathological examination, patch test, intradermal test, and oral provocation test, we established a final diagnosis of FDE due to valacyclovir without cross-reactivity to acyclovir. To find alternative therapeutic drugs, we suggest diagnostic tests with not only the suspected drugs, but also other drugs in the same class. The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2023-05 2023-05-15 /pmc/articles/PMC10608398/ /pubmed/37853866 http://dx.doi.org/10.5021/ad.21.074 Text en Copyright © The Korean Dermatological Association and The Korean Society for Investigative Dermatology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Choi, Yeon-Gu
Park, Hyeon Jeong
Yim, Sunmin
Lee, Heun Joo
Choi, Young Jun
Kim, Won-Serk
Lee, Ga-Young
Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir
title Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir
title_full Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir
title_fullStr Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir
title_full_unstemmed Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir
title_short Fixed Drug Eruption in a Patient Taking Valacyclovir without Cross-Reactivity to Acyclovir
title_sort fixed drug eruption in a patient taking valacyclovir without cross-reactivity to acyclovir
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608398/
https://www.ncbi.nlm.nih.gov/pubmed/37853866
http://dx.doi.org/10.5021/ad.21.074
work_keys_str_mv AT choiyeongu fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir
AT parkhyeonjeong fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir
AT yimsunmin fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir
AT leeheunjoo fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir
AT choiyoungjun fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir
AT kimwonserk fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir
AT leegayoung fixeddrugeruptioninapatienttakingvalacyclovirwithoutcrossreactivitytoacyclovir